

In situ hybridization is a molecular biology-based technology service that uses specific nucleic acid probes to hybridize with nucleic acids in cells or tissues to achieve precise quantitative positioning of specific DNA or RNA sequences. This technology combines the principles of molecular biology, histochemistry and cytology, and determines the location and quantity of the target sequence by observing the probe signal under a microscope.
The global In Situ Hybridization Technology Services market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (publisher)' newest research report, the “In Situ Hybridization Technology Services Industry Forecast” looks at past sales and reviews total world In Situ Hybridization Technology Services sales in 2022, providing a comprehensive analysis by region and market sector of projected In Situ Hybridization Technology Services sales for 2023 through 2029. With In Situ Hybridization Technology Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world In Situ Hybridization Technology Services industry.
This Insight Report provides a comprehensive analysis of the global In Situ Hybridization Technology Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on In Situ Hybridization Technology Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global In Situ Hybridization Technology Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for In Situ Hybridization Technology Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global In Situ Hybridization Technology Services.
United States market for In Situ Hybridization Technology Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for In Situ Hybridization Technology Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for In Situ Hybridization Technology Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key In Situ Hybridization Technology Services players cover Creative BioMart, Agilent Technologies, Enzo Life Sciences, Inc., OGT, Precision for Medicine, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of In Situ Hybridization Technology Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
DNA in Situ Hybridization
RNA in Situ Hybridization
Segmentation by Application:
Scientific Research
Agricultural
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
DNA in Situ Hybridization
RNA in Situ Hybridization
Segmentation by Application:
Scientific Research
Agricultural
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Creative BioMart
Agilent Technologies
Enzo Life Sciences, Inc.
OGT
Precision for Medicine
VitaScientific
Advanced Cell Diagnostics
Creative Diagnostics
Genemed CISH
Zytomed Systems GmbH
CLOUD-CLONE CORP.
CytoCell myProbes
Charles River
Bio-Techne
Daicel Arbor Biosciences
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global In Situ Hybridization Technology Services Market Size 2019-2030
2.1.2 In Situ Hybridization Technology Services Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for In Situ Hybridization Technology Services by Country/Region, 2019, 2023 & 2030
2.2 In Situ Hybridization Technology Services Segment by Type
2.2.1 DNA in Situ Hybridization
2.2.2 RNA in Situ Hybridization
2.3 In Situ Hybridization Technology Services Market Size by Type
2.3.1 In Situ Hybridization Technology Services Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global In Situ Hybridization Technology Services Market Size Market Share by Type (2019-2024)
2.4 In Situ Hybridization Technology Services Segment by Application
2.4.1 Scientific Research
2.4.2 Agricultural
2.4.3 Others
2.5 In Situ Hybridization Technology Services Market Size by Application
2.5.1 In Situ Hybridization Technology Services Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global In Situ Hybridization Technology Services Market Size Market Share by Application (2019-2024)
3 In Situ Hybridization Technology Services Market Size by Player
3.1 In Situ Hybridization Technology Services Market Size Market Share by Player
3.1.1 Global In Situ Hybridization Technology Services Revenue by Player (2019-2024)
3.1.2 Global In Situ Hybridization Technology Services Revenue Market Share by Player (2019-2024)
3.2 Global In Situ Hybridization Technology Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 In Situ Hybridization Technology Services by Region
4.1 In Situ Hybridization Technology Services Market Size by Region (2019-2024)
4.2 Global In Situ Hybridization Technology Services Annual Revenue by Country/Region (2019-2024)
4.3 Americas In Situ Hybridization Technology Services Market Size Growth (2019-2024)
4.4 APAC In Situ Hybridization Technology Services Market Size Growth (2019-2024)
4.5 Europe In Situ Hybridization Technology Services Market Size Growth (2019-2024)
4.6 Middle East & Africa In Situ Hybridization Technology Services Market Size Growth (2019-2024)
5 Americas
5.1 Americas In Situ Hybridization Technology Services Market Size by Country (2019-2024)
5.2 Americas In Situ Hybridization Technology Services Market Size by Type (2019-2024)
5.3 Americas In Situ Hybridization Technology Services Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC In Situ Hybridization Technology Services Market Size by Region (2019-2024)
6.2 APAC In Situ Hybridization Technology Services Market Size by Type (2019-2024)
6.3 APAC In Situ Hybridization Technology Services Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe In Situ Hybridization Technology Services Market Size by Country (2019-2024)
7.2 Europe In Situ Hybridization Technology Services Market Size by Type (2019-2024)
7.3 Europe In Situ Hybridization Technology Services Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa In Situ Hybridization Technology Services by Region (2019-2024)
8.2 Middle East & Africa In Situ Hybridization Technology Services Market Size by Type (2019-2024)
8.3 Middle East & Africa In Situ Hybridization Technology Services Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global In Situ Hybridization Technology Services Market Forecast
10.1 Global In Situ Hybridization Technology Services Forecast by Region (2025-2030)
10.1.1 Global In Situ Hybridization Technology Services Forecast by Region (2025-2030)
10.1.2 Americas In Situ Hybridization Technology Services Forecast
10.1.3 APAC In Situ Hybridization Technology Services Forecast
10.1.4 Europe In Situ Hybridization Technology Services Forecast
10.1.5 Middle East & Africa In Situ Hybridization Technology Services Forecast
10.2 Americas In Situ Hybridization Technology Services Forecast by Country (2025-2030)
10.2.1 United States Market In Situ Hybridization Technology Services Forecast
10.2.2 Canada Market In Situ Hybridization Technology Services Forecast
10.2.3 Mexico Market In Situ Hybridization Technology Services Forecast
10.2.4 Brazil Market In Situ Hybridization Technology Services Forecast
10.3 APAC In Situ Hybridization Technology Services Forecast by Region (2025-2030)
10.3.1 China In Situ Hybridization Technology Services Market Forecast
10.3.2 Japan Market In Situ Hybridization Technology Services Forecast
10.3.3 Korea Market In Situ Hybridization Technology Services Forecast
10.3.4 Southeast Asia Market In Situ Hybridization Technology Services Forecast
10.3.5 India Market In Situ Hybridization Technology Services Forecast
10.3.6 Australia Market In Situ Hybridization Technology Services Forecast
10.4 Europe In Situ Hybridization Technology Services Forecast by Country (2025-2030)
10.4.1 Germany Market In Situ Hybridization Technology Services Forecast
10.4.2 France Market In Situ Hybridization Technology Services Forecast
10.4.3 UK Market In Situ Hybridization Technology Services Forecast
10.4.4 Italy Market In Situ Hybridization Technology Services Forecast
10.4.5 Russia Market In Situ Hybridization Technology Services Forecast
10.5 Middle East & Africa In Situ Hybridization Technology Services Forecast by Region (2025-2030)
10.5.1 Egypt Market In Situ Hybridization Technology Services Forecast
10.5.2 South Africa Market In Situ Hybridization Technology Services Forecast
10.5.3 Israel Market In Situ Hybridization Technology Services Forecast
10.5.4 Turkey Market In Situ Hybridization Technology Services Forecast
10.6 Global In Situ Hybridization Technology Services Forecast by Type (2025-2030)
10.7 Global In Situ Hybridization Technology Services Forecast by Application (2025-2030)
10.7.1 GCC Countries Market In Situ Hybridization Technology Services Forecast
11 Key Players Analysis
11.1 Creative BioMart
11.1.1 Creative BioMart Company Information
11.1.2 Creative BioMart In Situ Hybridization Technology Services Product Offered
11.1.3 Creative BioMart In Situ Hybridization Technology Services Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Creative BioMart Main Business Overview
11.1.5 Creative BioMart Latest Developments
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Information
11.2.2 Agilent Technologies In Situ Hybridization Technology Services Product Offered
11.2.3 Agilent Technologies In Situ Hybridization Technology Services Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Agilent Technologies Main Business Overview
11.2.5 Agilent Technologies Latest Developments
11.3 Enzo Life Sciences, Inc.
11.3.1 Enzo Life Sciences, Inc. Company Information
11.3.2 Enzo Life Sciences, Inc. In Situ Hybridization Technology Services Product Offered
11.3.3 Enzo Life Sciences, Inc. In Situ Hybridization Technology Services Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Enzo Life Sciences, Inc. Main Business Overview
11.3.5 Enzo Life Sciences, Inc. Latest Developments
11.4 OGT
11.4.1 OGT Company Information
11.4.2 OGT In Situ Hybridization Technology Services Product Offered
11.4.3 OGT In Situ Hybridization Technology Services Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 OGT Main Business Overview
11.4.5 OGT Latest Developments
11.5 Precision for Medicine
11.5.1 Precision for Medicine Company Information
11.5.2 Precision for Medicine In Situ Hybridization Technology Services Product Offered
11.5.3 Precision for Medicine In Situ Hybridization Technology Services Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Precision for Medicine Main Business Overview
11.5.5 Precision for Medicine Latest Developments
11.6 VitaScientific
11.6.1 VitaScientific Company Information
11.6.2 VitaScientific In Situ Hybridization Technology Services Product Offered
11.6.3 VitaScientific In Situ Hybridization Technology Services Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 VitaScientific Main Business Overview
11.6.5 VitaScientific Latest Developments
11.7 Advanced Cell Diagnostics
11.7.1 Advanced Cell Diagnostics Company Information
11.7.2 Advanced Cell Diagnostics In Situ Hybridization Technology Services Product Offered
11.7.3 Advanced Cell Diagnostics In Situ Hybridization Technology Services Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Advanced Cell Diagnostics Main Business Overview
11.7.5 Advanced Cell Diagnostics Latest Developments
11.8 Creative Diagnostics
11.8.1 Creative Diagnostics Company Information
11.8.2 Creative Diagnostics In Situ Hybridization Technology Services Product Offered
11.8.3 Creative Diagnostics In Situ Hybridization Technology Services Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Creative Diagnostics Main Business Overview
11.8.5 Creative Diagnostics Latest Developments
11.9 Genemed CISH
11.9.1 Genemed CISH Company Information
11.9.2 Genemed CISH In Situ Hybridization Technology Services Product Offered
11.9.3 Genemed CISH In Situ Hybridization Technology Services Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Genemed CISH Main Business Overview
11.9.5 Genemed CISH Latest Developments
11.10 Zytomed Systems GmbH
11.10.1 Zytomed Systems GmbH Company Information
11.10.2 Zytomed Systems GmbH In Situ Hybridization Technology Services Product Offered
11.10.3 Zytomed Systems GmbH In Situ Hybridization Technology Services Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Zytomed Systems GmbH Main Business Overview
11.10.5 Zytomed Systems GmbH Latest Developments
11.11 CLOUD-CLONE CORP.
11.11.1 CLOUD-CLONE CORP. Company Information
11.11.2 CLOUD-CLONE CORP. In Situ Hybridization Technology Services Product Offered
11.11.3 CLOUD-CLONE CORP. In Situ Hybridization Technology Services Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 CLOUD-CLONE CORP. Main Business Overview
11.11.5 CLOUD-CLONE CORP. Latest Developments
11.12 CytoCell myProbes
11.12.1 CytoCell myProbes Company Information
11.12.2 CytoCell myProbes In Situ Hybridization Technology Services Product Offered
11.12.3 CytoCell myProbes In Situ Hybridization Technology Services Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 CytoCell myProbes Main Business Overview
11.12.5 CytoCell myProbes Latest Developments
11.13 Charles River
11.13.1 Charles River Company Information
11.13.2 Charles River In Situ Hybridization Technology Services Product Offered
11.13.3 Charles River In Situ Hybridization Technology Services Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Charles River Main Business Overview
11.13.5 Charles River Latest Developments
11.14 Bio-Techne
11.14.1 Bio-Techne Company Information
11.14.2 Bio-Techne In Situ Hybridization Technology Services Product Offered
11.14.3 Bio-Techne In Situ Hybridization Technology Services Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Bio-Techne Main Business Overview
11.14.5 Bio-Techne Latest Developments
11.15 Daicel Arbor Biosciences
11.15.1 Daicel Arbor Biosciences Company Information
11.15.2 Daicel Arbor Biosciences In Situ Hybridization Technology Services Product Offered
11.15.3 Daicel Arbor Biosciences In Situ Hybridization Technology Services Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Daicel Arbor Biosciences Main Business Overview
11.15.5 Daicel Arbor Biosciences Latest Developments
12 Research Findings and Conclusion
*If Applicable.